Endocannabinoids: Friends and foes of reproduction

Progress in Lipid Research

Volumn 48, Issue 6, 2009, Pages 344-354

  Maccarrone, Mauro ^a,b  

^a UNIVERSITY OF TERAMO   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Endocannabinoid system; Human reproduction; Metabolism; Oocyte; Oviduct; Placenta; Signal transduction; Sperm

Indexed keywords

ANANDAMIDE; CANNABINOID RECEPTOR; ENDOCANNABINOID; FATTY ACID AMIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RIMONABANT; VANILLOID RECEPTOR;

ACROSOME REACTION; CELL INTERACTION; CELL SURVIVAL; CLINICAL TRIAL; CYTOLOGY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE MARKER; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; ECTOPIC PREGNANCY; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE FERTILITY; FEMALE GENITAL SYSTEM; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; GENETIC PREDISPOSITION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIPID METABOLISM; MALE FERTILITY; MALE GENITAL SYSTEM; MALE INFERTILITY; MAMMAL; NIDATION; NONHUMAN; OBESITY; OOCYTE MATURATION; OVULATION; PLACENTA DEVELOPMENT; PREMATURITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SEQUENCE HOMOLOGY; SERTOLI CELL; SIGNAL TRANSDUCTION; SPERMATOGENESIS; SPERMATOZOON CAPACITATION; SPERMATOZOON MOTILITY; SPONTANEOUS ABORTION;

ENDOCANNABINOIDS; FALLOPIAN TUBES; FEMALE; FERTILITY; HUMANS; MALE; OOCYTES; PLACENTA; PREGNANCY; REPRODUCTION; SPERMATOZOA;

EID: 70350072546     PISSN: 01637827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plipres.2009.07.001     Document Type: Review

References (110)

1. Evers J.L. Female subfertility. Lancet 360 (2002) 151-159
2. Gnoth C., Godehardt E., Frank-Herrmann P., Friol K., Tigges J., and Freundl G. Definition and prevalence of subfertility and infertility. Hum Reprod 20 (2005) 1144-1147
3. Lewis S.E., and Maccarrone M. Endocannabinoids, sperm biology and human fertility. Pharmacol Res 60 (2009) 126-131
4. Andersen A.N., Goossens V., Ferraretti A.P., Bhattacharya S., Felberbaum R., de Mouzon J., et al. Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Hum Reprod 23 (2008) 756-771
5. Full contents at: .
6. Piomelli D. THC: moderation during implantation. Nat Med 10 (2004) 19-20
7. Maccarrone M., Valensise H., Bari M., Lazzarin N., Romanini C., and Finazzi-Agrò A. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet 355 (2000) 1326-1329
8. Habayeb O.M., Taylor A.H., Finney M., Evans M.D., and Konje J.C. Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. JAMA 299 (2008) 1135-1136
9. Bari M., Battista N., Fezza F., Gasperi V., and Maccarrone M. New insights into endocannabinoid degradation and its therapeutic potential. Mini Rev Med Chem 6 (2006) 257-268
10. Di Marzo V. Targeting the endocannabinoid system: to enhance or reduce?. Nat Rev Drug Discov 7 (2008) 438-455
11. Ho W.S., Barrett D.A., and Randall M.D. "Entourage" effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Br J Pharmacol 155 (2008) 837-846
12. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54 (2002) 161-202
13. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310 (2005) 329-332
14. Starowicz K., Nigam S., and Di Marzo V. Biochemistry and pharmacology of endovanilloids. Pharmacol Ther 114 (2007) 13-33
15. Gasperi V., Fezza F., Pasquariello N., Bari M., Oddi S., Finazzi-Agrò A., et al. Endocannabinoids in adipocytes during differentiation and their role in glucose uptake. Cell Mol Life Sci 64 (2007) 219-229
16. Basavarajappa B.S. The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism. Mini Rev Med Chem 7 (2007) 769-779
17. Okamoto Y., Morishita J., Tsuboi K., Tonai T., and Ueda N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279 (2004) 5298-5305
18. McKinney M.K., and Cravatt B.F. Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74 (2005) 411-432
19. Duttaroy A.K. Transport of fatty acids across the human placenta: a review. Prog Lipid Res 48 (2009) 52-61
20. Battista N., Gasperi V., Fezza F., and Maccarrone M. The anandamide membrane transporter and the therapeutic implications of its inhibition. Therapy 2 (2005) 141-150
21. Hermann A., Kaczocha M., and Deutsch D.G. 2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook. AAPS J 8 (2006) E409-E412
22. Mechoulam R., and Deutsch D.G. Toward an anandamide transporter. Proc Natl Acad Sci USA 102 (2005) 17541-17542
23. Oddi S., Fezza F., Pasquariello N., De Simone C., Rapino C., Dainese E., et al. Evidence for the intracellular accumulation of anandamide in adiposomes. Cell Mol Life Sci 65 (2008) 840-850
24. Kaczocha M., Glaser S.T., and Deutsch D.G. Identification of intracellular carriers for the endocannabinoid anandamide. Proc Natl Acad Sci USA 106 (2009) 6375-6380
25. Oddi S., Fezza F., Pasquariello N., D'Agostino A., Catanzaro G., De Simone C., et al. Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins. Chem Biol 16 (2009) 624-634
26. Van der Stelt M., van Kuik J.A., Bari M., van Zadelhoff G., Leeflang B.R., Veldink G.A., et al. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. J Med Chem 45 (2002) 3709-3720
27. Rouzer C.A., and Marnett L.J. Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids. J Biol Chem 283 (2008) 8065-8069
28. Snider N.T., Sikora M.J., Sridar C., Feuerstein T.J., Rae J.M., and Hollenberg P.F. The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. J Pharmacol Exp Ther 327 (2008) 538-545
29. Bisogno T., Howell F., Williams G., Minassi A., Cascio M.G., Ligresti A., et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163 (2003) 463-468
30. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99 (2002) 10819-10824
31. Ligresti A., Cascio M.G., and Di Marzo V. Endocannabinoid metabolic pathways and enzymes. Curr Drug Targets CNS Neurol Disord 4 (2005) 615-623
32. Lauckner J.E., Jensen J.B., Chen H.Y., Lu H.C., Hille B., and Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci USA 105 (2008) 2699-2704
33. Ross R.A. The enigmatic pharmacology of GPR55. Trends Pharmacol Sci 30 (2009) 156-163
34. Díaz-Laviada I., and Ruiz-Llorente L. Signal transduction activated by cannabinoid receptors. Mini Rev Med Chem 5 (2005) 619-630
35. Maccarrone M., Rossi S., Bari M., De Chiara V., Fezza F., Musella A., et al. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat Neurosci 11 (2008) 152-159
36. Bensinger S.J., and Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454 (2008) 470-477
37. O'Sullivan S.E. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol 152 (2007) 576-582
38. Katona I., and Freund T.F. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 14 (2008) 923-930
39. Klein T.W. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 5 (2005) 400-411
40. Pacher P., Mukhopadhyay P., Mohanraj R., Godlewski G., Bátkai S., and Kunos G. Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations. Hypertension 52 (2008) 601-607
41. Cota D. Role of the endocannabinoid system in energy balance regulation and obesity. Front Horm Res 36 (2008) 135-145
42. Kunos G., Osei-Hyiaman D., Liu J., Godlewski G., and Bátkai S. Endocannabinoids and the control of energy homeostasis. J Biol Chem 283 (2008) 33021-33025
43. Schuel H., and Burkman L.J. A tale of two cells: endocannabinoid-signaling regulates functions of neurons and sperm. Biol Reprod 73 (2005) 1078-1086
44. Wang H., Dey S.K., and Maccarrone M. Jekyll and hyde: two faces of cannabinoid signaling in male and female fertility. Endocr Rev 27 (2006) 427-448
45. Taylor A.H., Ang C., Bell S.C., and Konje J.C. The role of the endocannabinoid system in gametogenesis, implantation and early pregnancy. Hum Reprod Update 13 (2007) 501-513
46. Battista N., Pasquariello N., Di Tommaso M., and Maccarrone M. Interplay between endocannabinoids, steroids and cytokines in the control of human reproduction. J Neuroendocrinol 20 (2008) 82-89
47. Rossato M., Pagano C., and Vettor R. The cannabinoid system and male reproductive functions. J Neuroendocrinol 20 (2008) 90-93
48. Sun X., and Dey S.K. Aspects of endocannabinoid signaling in periimplantation biology. Mol Cell Endocrinol 286 (2008) 3-11
49. Maccarrone M. CB2 receptors in reproduction. Br J Pharmacol 153 (2008) 189-198
50. Maccarrone M. Endocannabinoids and reproductive endocrinology. Curr Opin Investig Drugs 10 (2009) 305-310
51. Maccarrone M, Gasperi V, Bari M, Avigliano L, Finazzi-Agrò A. Gli endocannabinoidi: nuovi mediatori lipidici di rilevanza biomedica. Piccin Nuova Libraria: Padua (Italy); 2009.
52. Wang H., Xie H., Sun X., Kingsley P.J., Marnett L.J., Cravatt B.F., et al. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. Prostaglandins Other Lipid Mediat 83 (2007) 62-74
53. Peralta L, Agirregoitia E, Mendoza R, Exposito A, Matrorras R, Agirregoitia N. Human oocytes express CB1 and CB2 cannabinoid receptors and their localization changes in the different oocyte maturation stages. In: IV European workshop on cannabinoid research (7-10 May 2009, S. Lorenzo de El Escorial, Madrid, Spain). p. 146.
54. Schuel H., Burkman L.J., Lippes J., Crickard K., Forester E., Piomelli D., et al. N-Acylethanolamines in human reproductive fluids. Chem Phys Lipids 121 (2002) 211-227
55. El-Talatini M.R., Taylor A.H., Elson J.C., Brown L., Davidson A.C., and Konje J.C. Localisation and function of the endocannabinoid system in the human ovary. PLoS ONE 4 (2009) e4579
56. El-Talatini M.R., Taylor A.H., and Konje J.C. Fluctuation in anandamide levels from ovulation to early pregnancy in in-vitro fertilization-embryo transfer women, and its hormonal regulation. Hum Reprod 1 24 (2009) 1989-1998
57. Wang H., Xie H., Guo Y., Zhang H., Takahashi T., Kingsley P.J., et al. Fatty acid amide hydrolase deficiency limits early pregnancy events. J Clin Invest 116 (2006) 2122-2131
58. Schuel H. Tuning the oviduct to the anandamide tone. J Clin Invest 116 (2006) 2087-2090
59. Horne A.W., Phillips III J.A., Kane N., Lourenco P.C., McDonald S.E., Williams A.R., et al. CB1 expression is attenuated in Fallopian tube, decidua of women with ectopic pregnancy. PLoS ONE 3 (2008) e3969
60. Dainese E., Oddi S., and Maccarrone M. Lipid-mediated dimerization of beta2-adrenergic receptor reveals important clues for cannabinoid receptors. Cell Mol Life Sci 65 (2008) 2277-2279
61. Guo Y., Wang H., Okamoto Y., Ueda N., Kingsley P.J., Marnett L.J., et al. N-Acylphosphatidylethanolaminehydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J Biol Chem 280 (2005) 23429-23432
62. Maccarrone M., De Felici M., Klinger F.G., Battista N., Fezza F., Dainese E., et al. Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus. Mol Hum Reprod 10 (2004) 215-221
63. Turco M.Y., Matsukawa K., Czernik M., Gasperi V., Battista N., Della Salda L., et al. High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation. Hum Reprod 23 (2008) 2331-2338
64. Maccarrone M., Bisogno T., Valensise H., Lazzarin N., Fezza F., Manna C., et al. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol Hum Reprod (2002) 188-195
65. Wang H., Xie H., and Dey S.K. Loss of cannabinoid receptor CB1 induces preterm birth. PLoS ONE 3 (2008) e3320
66. Helliwell R.J., Chamley L.W., Blake-Palmer K., Mitchell M.D., Wu J., Kearn C.S., et al. Characterization of the endocannabinoid system in early human pregnancy. J Clin Endocrinol Metab 89 (2004) 5168-5174
67. Habayeb O.M., Taylor A.H., Bell S.C., Taylor D.J., and Konje J.C. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. Endocrinology 149 (2008) 5052-5060
68. Trabucco E., Acone G., Marenna A., Pierantoni R., Cacciola G., Chioccarelli T., et al. Endocannabinoid system in first trimester placenta: low FAAH and high CB1 expression characterize spontaneous miscarriage. Placenta 30 (2009) 516-522
69. Acone G., Trabucco E., Colacurci N., Cobellis L., Mackie K., Meccariello R., et al. Low type I cannabinoid receptor levels characterize placental villous in labouring delivery. Placenta 30 (2009) 203-205
70. Habayeb O.M., Taylor A.H., Evans M.D., Cooke M.S., Taylor D.J., Bell S.C., et al. Plasma levels of the endocannabinoid anandamide in women-a potential role in pregnancy maintenance and labor?. J Clin Endocrinol Metab 89 (2004) 5482-5487
71. Chamley L.W., Bhalla A., Stone P.R., Liddell H., O'Carroll S., Kearn C., et al. Nuclear localisation of the endocannabinoid metabolizing enzyme fatty acid amide hydrolase (FAAH) in invasive trophoblasts and an association with recurrent miscarriage. Placenta 29 (2008) 970-975
72. Mitchell M.D., Sato T.A., Wang A., Keelan J.A., Ponnampalam A.P., and Glass M. Cannabinoids stimulate prostaglandin production by human gestational tissues through a tissue- and CB1-receptor-specific mechanism. Am J Physiol Endocrinol Metab 294 (2008) 352-356
73. Cella M., Leguizamón G.F., Sordelli M.S., Cervini M., Guadagnoli T., Ribeiro M.L., et al. Dual effect of anandamide on rat placenta nitric oxide synthesis. Placenta 29 (2008) 699-707
74. Cacciola G., Chioccarelli T., Mackie K., Meccariello R., Ledent C., Fasano S., et al. Expression of type-1 cannabinoid receptor during rat postnatal testicular development: possible involvement in adult leydig cell differentiation. Biol Reprod 79 (2008) 758-765
75. Foresta C., Bettella A., Merico M., Garolla A., Plebani M., Ferlin A., et al. FSH in the treatment of oligozoospermia. Mol Cell Endocrinol 161 (2000) 89-97
76. Park B., McPartland J.M., and Glass M. Cannabis, cannabinoids and reproduction. Prostagl Leukotr Essent Fatty Acids 70 (2004) 189-197
77. Maccarrone M., and Wenger T. Effects of cannabinoids on hypothalamic and reproductive function. Handb Exp Pharmacol 168 (2005) 555-571
78. Maccarrone M., Cecconi S., Rossi G., Battista N., Pauselli R., and Finazzi-Agrò A. Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells. Endocrinology 144 (2003) 20-28
79. Pentikaïnen V., Erkkilä K., Suomalainen L., Parvinen M., and Dunkel L. Estradiol acts as a germ cell survival factor in the human testis in vitro. J Clin Endocrinol Metab 85 (2000) 2057-2067
80. McDonald C.A., Millena A.C., Reddy S., Finlay S., Vizcarra J., Khan S.A., et al. Follicle-stimulating hormone-induced aromatase in immature rat Sertoli cells requires an active phosphatidylinositol 3-kinase pathway and is inhibited via the mitogen-activated protein kinase signaling pathway. Mol Endocrinol 20 (2006) 608-618
81. Rossi G., Gasperi V., Paro R., Barsacchi D., Cecconi S., and Maccarrone M. Follicle-stimulating hormone activates fatty acid amide hydrolase by protein kinase A and aromatase-dependent pathways in mouse primary Sertoli cells. Endocrinology 148 (2007) 1431-1439
82. Puffenbarger R.A. Molecular biology of the enzymes that degrade endocannabinoids. Curr Drug Targets CNS Neurol Disord 4 (2005) 625-631
83. Grimaldi P., Rossi G., Catanzaro G., and Maccarrone M. Modulation of the endocannabinoid-degrading enzyme fatty acid amide hydrolase by follicle-stimulating hormone. Vitam Horm 81 (2009) 231-261
84. Wenger T., Ledent C., Csernus V., and Gerendai I. The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. Biochem Biophys Res Commun 284 (2001) 363-368
85. Cacciola G., Chioccarelli T., Ricci G., Meccariello R., Fasano S., Pierantoni R., et al. The endocannabinoid system in vertebrate male reproduction: a comparative overview. Mol Cell Endocrinol 286 (2008) S24-S30
86. Grimaldi P., Orlando P., Di Siena S., Lolicato F., Petrosino S., Bisogno T., et al. The endocannabinoid system and pivotal role of the CB2 receptor in mouse spermatogenesis. Proc Natl Acad Sci USA 106 (2009) 11131-11136
87. Rossato M., Ion Popa F., Ferigo M., Clari G., and Foresta C. Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. J Clin Endocrinol Metab 90 (2005) 984-991
88. Maccarrone M., Barboni B., Paradisi A., Bernabo N., Gasperi V., Pistilli M.G., et al. Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction. J Cell Sci 118 (2005) 4393-4404
89. Ricci G., Cacciola G., Altucci L., Meccariello R., Pierantoni R., Fasano S., et al. Endocannabinoid control of sperm motility: the role of epididymus. Gen Comp Endocrinol 153 (2007) 320-322
90. Sun X., Wang H., Okabe M., Mackie K., Kingsley P.J., Marnett L.J., et al. Genetic loss of Faah compromises male fertility in mice. Biol Reprod 80 (2009) 235-242
91. Gervasi M.G., Rapanelli M., Ribeiro M.L., Farina M., Billi S., Franchi A.M., et al. The endocannabinoid system in bull sperm and bovine oviductal epithelium: role of anandamide in sperm-oviduct interaction. Reproduction 137 (2009) 403-414
92. 2+ mobilization essential for acrosome reaction in sperm. J Cell Biol 161 (2003) 79-88
93. 2+-channel responses: initial events in sperm activation. Development 130 (2003) 1317-1326
94. Gadella B.M., and Harrison R.A. The capacitating agent bicarbonate induces protein kinase A-dependent changes in phospholipid transbilayer behaviour in the sperm plasma membrane. Development 127 (2000) 2407-2420
95. Suarez S.S., and Ho H.C. Hyperactivation of mammalian sperm. Cell Mol Biol 49 (2003) 351-356
96. Agirregoitia E, Carracedo A, Subirán N, Valdivia A, Agirregoitia N, Peralta L, et al. The CB(2) cannabinoid receptor regulates human sperm cell motility. Fertil Steril 2009. doi:10.1016/j.fertnstert.2009.01.153.
97. Francavilla F., Barbonetti A., Battista N., Vassallo M.R.C., Antonangelo C., Barnabò N., et al. Characterization of the endocannabinoid system in human sperm, functional role of type-1 vanilloid receptor. Int J Androl 31 (2008) 24
98. Chapman K.D. Occurrence, metabolism, and prospective functions of N-acylethanolamines in plants. Prog Lipid Res 43 (2004) 302-327
99. Fasano S., Meccariello R., Cobellis G., Chianese R., Cacciola G., Chioccarelli T., et al. The endocannabinoid system: an ancient signaling involved in the control of male fertility. Ann NY Acad Sci 1163 (2009) 112-124
100. Chang M.C., Berkery D., Schuel R., Laychock S.G., Zimmerman A.M., Zimmerman S., et al. Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction. Mol Reprod Dev 36 (1993) 507-516
101. Schuel H., Goldstein E., Mechoulam R., Zimmerman A.M., and Zimmerman S. Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction. Proc Natl Acad Sci USA 91 (1994) 7678-7682
102. Materna S.C., and Cameron R.A. The sea urchin genome as a window on function. Biol Bull 214 (2008) 266-273
103. Cottone E., Guastalla A., Mackie K., and Franzoni M.F. Endocannabinoids affect the reproductive functions in teleosts and amphibians. Mol Cell Endocrinol 286 (2008) S41-S45
104. Yamaguchi F., Macrae A.D., and Brenner S. Molecular cloning of two cannabinoid type 1-like receptor genes from the puffer fish Fugu rubripes. Genomics 35 (1996) 603-605
105. Meccariello R., Chianese R., Cacciola G., Cobellis G., Pierantoni R., and Fasano S. Type-1 cannabinoid receptor expression in the frog, Rana esculenta, tissues: a possible involvement in the regulation of testicular activity. Mol Reprod Dev 73 (2006) 551-558
106. Cobellis G., Cacciola G., Scarpa D., Meccariello R., Chianese R., Franzoni M.F., et al. Endocannabinoid system in frog and rodent testis: type-1 cannabinoid receptor and fatty acid amide hydrolase activity in male germ cells. Biol Reprod 75 (2006) 82-89
107. Cravatt B.F., Demarest K., Patricelli M.P., Bracey M.H., Giang D.K., Martin B.R., et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98 (2001) 9371-9376
108. Fezza F., De Simone C., Amadio D., and Maccarrone M. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system. Subcell Biochem 49 (2008) 101-132
109. Mukul L.V., and Teal S.B. Current management of ectopic pregnancy. Obstet Gynecol Clin North Am 34 (2007) 403-419
110. Maccarrone M., and Wang H. Dey SK Antagonism of type-1 cannabinoid receptors: good for obesity, but is it safe for fertility?. Clin Endocrinol 66 (2007) 456-457